This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Jul 3;320(1):35-37.

doi: 10.1001/jama.2018.7911.

Replacing the Pap Test With Screening Based on Human Papillomavirus Assays

L Stewart Massad¹

Affiliations

PMID: 29971379
DOI: 10.1001/jama.2018.7911

Editorial

Replacing the Pap Test With Screening Based on Human Papillomavirus Assays

L Stewart Massad. JAMA. 2018.

. 2018 Jul 3;320(1):35-37.

doi: 10.1001/jama.2018.7911.

Author

L Stewart Massad¹

Affiliation

¹ Department of Obstetrics and Gynecology, Washington University School of Medicine in St Louis, St Louis, Missouri.

PMID: 29971379
DOI: 10.1001/jama.2018.7911

Erratum in

Colposcopy Rates Reported Incorrectly.
[No authors listed] [No authors listed] JAMA. 2018 Aug 14;320(6):605. doi: 10.1001/jama.2018.10881. JAMA. 2018. PMID: 30120459 No abstract available.

No abstract available

PubMed Disclaimer

Comment in

Methods of Screening for Cervical Cancer.
Tang GY, Parekh J. Tang GY, et al. JAMA. 2018 Nov 13;320(18):1938-1939. doi: 10.1001/jama.2018.13939. JAMA. 2018. PMID: 30422188 No abstract available.

Comment on

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ. Ogilvie GS, et al. JAMA. 2018 Jul 3;320(1):43-52. doi: 10.1001/jama.2018.7464. JAMA. 2018. PMID: 29971397 Free PMC article. Clinical Trial.

Similar articles

Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A, van Niekerk D, Smith L, Ogilvie G. Coldman A, et al. J Med Screen. 2017 Dec;24(4):195-200. doi: 10.1177/0969141316673673. Epub 2016 Nov 3. J Med Screen. 2017. PMID: 27810984
HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
Stoler MH. Stoler MH. J Histochem Cytochem. 2001 Sep;49(9):1197-8. doi: 10.1177/002215540104900918. J Histochem Cytochem. 2001. PMID: 11511693
Homage to Georgios Papanikolaou: A pilgrimage to his birthplace.
Franco EL. Franco EL. Cancer Cytopathol. 2023 Sep;131(9):546-547. doi: 10.1002/cncy.22734. Epub 2023 Jun 10. Cancer Cytopathol. 2023. PMID: 37300385 No abstract available.
Exhortations to abandon the Pap test as a routine initial cervical screening test are still premature and carry significant risks.
Austin RM. Austin RM. Diagn Cytopathol. 2010 Nov;38(11):783-7. doi: 10.1002/dc.21350. Diagn Cytopathol. 2010. PMID: 20607804 Review. No abstract available.
[Screening of cervical cancer--update].
Dvorák V, Ondrus J. Dvorák V, et al. Ceska Gynekol. 2010 Feb;75(1):65-8. Ceska Gynekol. 2010. PMID: 20437841 Review. Czech.

See all similar articles

Cited by

Assessing Physician Adherence to Guidelines for Cervical Cancer Screening and Management of Abnormal Screening Results.
Min CJ, Massad LS, Dick R, Powell MA, Kuroki LM. Min CJ, et al. J Low Genit Tract Dis. 2020 Oct;24(4):337-342. doi: 10.1097/LGT.0000000000000558. J Low Genit Tract Dis. 2020. PMID: 32976292 Free PMC article.
Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women.
Chambuso R, Ramesar R, Kaambo E, Murahwa AT, Abdallah MOE, De Sousa M, Denny L, Williamson AL, Gray CM. Chambuso R, et al. Medicine (Baltimore). 2020 Feb;99(9):e19273. doi: 10.1097/MD.0000000000019273. Medicine (Baltimore). 2020. PMID: 32118737 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program